Results 151 to 160 of about 6,902 (197)

Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine. [PDF]

open access: yesBlood Adv
Zhao LP   +15 more
europepmc   +1 more source

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial. [PDF]

open access: yesJ Clin Oncol
Mohty M   +19 more
europepmc   +1 more source

L'implantation et l'extension du choléra en Afrique noire : 1970-1980 [PDF]

open access: yes, 1983
Carme, B.   +4 more
core  

A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib. [PDF]

open access: yesERJ Open Res
Basin S   +10 more
europepmc   +1 more source

Les malnutritions dans les pays du Tiers-Monde [PDF]

open access: yes, 1986
Agbor Egbé, T.   +2 more
core  

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients. [PDF]

open access: yesAnn Hematol
Osanno L   +16 more
europepmc   +1 more source

Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort. [PDF]

open access: yesJ Hematol Oncol
Cortes J   +15 more
europepmc   +1 more source

Correction to: VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease. [PDF]

open access: yesAdv Ther
Mezalek ZT   +10 more
europepmc   +1 more source

Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study. [PDF]

open access: yesRes Pract Thromb Haemost
Olasupo OO   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy